A follow-up to the much longer report on Insulin (test on this later) and how PBMs impact pricing on other drugs. “Insulin A Drug Pricing Analysis,” Angry Bear. “Drug manufacturers alone set and raise drug prices, and PBMs are holding drug companies accountable by negotiating the lowest possible cost for drugs, including insulins, on behalf […]
I copied the two paragraphs below (actually I took one and split it) from Matt Stoller’s Big News Letter. Matt is talking about the same issues I have been talking about for years. The Pharmaceutical Industry and their rip off pricing. It is a good read if you wonder over there. The YouTube is also […]
There are seventy-one pages to this FTC report. My commentary looks at 5 edited (mine) pages of the report. The intent is to introduce you to Pharmacy Benefit Managers (PBMs) and the control they have over the market. The services they provide has been integrated with the healthcare insurance companies. Which makes this a dynamic […]
AB: This brief article gets right down to the basics in where costs are added and impacting the prices to the consumer. It is simple and straight to the point of how PBMs impact the prices to the consumer. Very little or nothing was contributed by myself to this article by the authors Inmaculada Hernandez; […]
This is the second part of the ABC 6 On Your Side web series on hidden reasons for high drug costs, we’ll show you why you may never see that aid. If you had time, you may have read Part One. It covered how Ohio HB 135 lingered till it died by not taking the […]
This is Part 1 of a three-part story of how politics and delays backed by commercial interests and business sponsor groups delayed and eventually killed a bill meant to aid Ohio citizens. Kind of a forerunner to what may happen if Congress ever promotes a bill for healthcare-for-all. I will post the other two parts […]
While briefly discussing (accessible link below for addition information) this decision, keep in mind this is a big deal in lowering the costs of pharmaceuticals as it goes right to the source of some of the excess takings involved in the distribution of drugs from manufacturer to drug stores. December 10, 2020: the Supreme Court […]